Growth Metrics

Cellebrite DI (CLBT) Non Operating Investment Income (2021 - 2025)

Cellebrite DI's Non Operating Investment Income history spans 5 years, with the latest figure at $16000.0 for Q4 2025.

  • Quarterly Non Operating Investment Income rose 103.89% to $16000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$976000.0 through Dec 2025, down 583.17% year-over-year, with the annual reading at $317000.0 for FY2025, 180.53% up from the prior year.
  • Non Operating Investment Income came in at $16000.0 for Q4 2025, down from $198000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $844000.0 in Q3 2024 to a low of -$1.4 million in Q1 2021.
  • The 5-year median for Non Operating Investment Income is -$47500.0 (2023), against an average of -$202500.0.
  • The largest YoY upside for Non Operating Investment Income was 870.11% in 2024 against a maximum downside of 1090.91% in 2024.
  • Cellebrite DI's Non Operating Investment Income stood at $120000.0 in 2021, then plummeted by 63.33% to $44000.0 in 2022, then soared by 565.91% to $293000.0 in 2023, then crashed by 240.27% to -$411000.0 in 2024, then skyrocketed by 103.89% to $16000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Non Operating Investment Income are $16000.0 (Q4 2025), $198000.0 (Q3 2025), and -$779000.0 (Q1 2025).